These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Current insulin infusion set failure criteria may be too stringent for real-life settings and may skew infusion set failure outcomes in extended-wear infusion set studies. Kastner JR; Poettler T; Kopanz J; Hochfellner DA; Romey M; Baumann PM; Muchmore D; Strasma PJ; Mader JK Diabetes Obes Metab; 2023 Apr; 25(4):1106-1111. PubMed ID: 36482830 [No Abstract] [Full Text] [Related]
11. Insulin Pump Infusion Set Failures Associated with Prolonged Hyperglycemia: Frequency and Relationship to Age and Type of Infusion Set During 22,741 Infusion Set Wears: Response to Letter to Editor. Kanapka LG; Lum JW; Beck RW Diabetes Technol Ther; 2022 Aug; 24(8):601-602. PubMed ID: 35913845 [No Abstract] [Full Text] [Related]
12. Overnight Counter-Regulatory Hormone Levels and Next Day Glycemia in Adults with Type 1 Diabetes During Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump with Low-Glucose Suspend. Graf A; Ward GM; Vogrin S; Sundararajan V; Sharifi A; De Bock MI; Jayawardene D; Loh MM; Horsburgh JC; Berthold CL; Paramalingam N; Bach LA; Colman PG; Davis EA; Grosman B; Jenkins AJ; Kumareswaran K; Kurtz N; Kyoong A; MacIsaac RJ; Roy A; Jones TW; O'Neal DN Diabetes Technol Ther; 2017 Jul; 19(7):438-439. PubMed ID: 28537427 [No Abstract] [Full Text] [Related]
13. Successful transitioning children and adolescents with type 1 diabetes from multiple daily injections to advanced hybrid closed-loop system in 10 days: a prospective intervention study on MiniMed 780G system. Petrovski G; Al Khalaf F; Campbell J; Day E; Almajaly D; Hussain K; Pasha M; Umer F; Hamdan M; Khalifa A Acta Diabetol; 2022 May; 59(5):743-746. PubMed ID: 35072781 [No Abstract] [Full Text] [Related]
14. Closed-loop insulin delivery in type 1 diabetes. Thabit H; Hovorka R Endocrinol Metab Clin North Am; 2012 Mar; 41(1):105-17. PubMed ID: 22575409 [TBL] [Abstract][Full Text] [Related]
15. Role of Continuous Glucose Monitoring in Insulin-Requiring Patients with Diabetes. Welsh JB Diabetes Technol Ther; 2018 Jun; 20(S2):S242-S249. PubMed ID: 29916736 [No Abstract] [Full Text] [Related]
16. Use of Machine Learning and Hybrid Closed Loop Insulin Delivery at Diabetes Camps. Taylor KA; Forlenza GP Diabetes Technol Ther; 2020 Jul; 22(7):535-537. PubMed ID: 32058821 [No Abstract] [Full Text] [Related]
17. Fully closed-loop insulin delivery-are we nearly there yet? Boughton CK Lancet Digit Health; 2021 Nov; 3(11):e689-e690. PubMed ID: 34580054 [No Abstract] [Full Text] [Related]
18. Nutrient intake, glycemic control, and body mass index in adolescents using continuous subcutaneous insulin infusion and those using traditional insulin therapy. Wilson MA; Smith CB Diabetes Educ; 2003; 29(2):230-2, 235-6, 238. PubMed ID: 12728751 [No Abstract] [Full Text] [Related]
19. Insulin Requirements Over Eight Weeks of Fully Closed-Loop Insulin Delivery in Adults With Type 2 Diabetes. Lakshman R; Daly AB; Nwokolo M; Hartnell S; Wilinska ME; Cezar A; Evans ML; Hovorka R; Boughton CK J Diabetes Sci Technol; 2023 May; 17(3):868-870. PubMed ID: 36912020 [No Abstract] [Full Text] [Related]
20. [What is the current state of the artificial pancreas in diabetes care?]. Dimou M; Laimer M; Stettler C; Bally L Internist (Berl); 2020 Jan; 61(1):102-109. PubMed ID: 31863132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]